Back to MREO

MARSHALL WACE, LLP → MREO

MARSHALL WACE, LLP MREO Position History

Mereo BioPharma Group plc • Healthcare

Quarters held
12
Latest value
$10K
Q3 2026
Peak value
$4.2M
First seen
Q4 2023

Dollar value over time

Show data table
PeriodPosition value
Q4 2023$34K
Q2 2024$4.1M
Q3 2024$4.2M
Q4 2024$3M
Q1 2025$1.7M
Q2 2025$2.1M
Q3 2025$1.6M
Q1 2026$26K
Q1 2026$200K
Q2 2026$11K
Q2 2026$47K
Q3 2026$10K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$10K24.0K——
Q2 2026$47K147.0K——
Q2 2026$11K32.9K——
Q1 2026$200K607.1K——
Q1 2026$26K79.9K——
Q3 2025$1.6M767.7K——
Q2 2025$2.1M767.7K——
Q1 2025$1.7M767.7K——
Q4 2024$3M866.3K——
Q3 2024$4.2M1.03M——
Q2 2024$4.1M1.14M——
Q4 2023$34K14.9K——

Other funds holding MREO

Other MARSHALL WACE, LLP positions

ETHA

ISHARES-S&P 500

$17B
IAU

ISHARES-S&P 500

$12B
ETHA

ISHARES-S&P 500

$11.5B
IAU

ISHARES-S&P 500

$11.1B
IAU

ISHARES-S&P 500

$10.7B
IAU

ISHARES-S&P 500

$10.3B
IAU

ISHARES-S&P 500

$9.9B
ETHA

ISHARES-S&P 500

$8.4B